Cotecna takes equity stake in consumer product testing firm ACT Lab

What's the deal? CotecnaDealroom has a profile for this one. Try Dealroom → , a Geneva-based provider of testing, inspection, and certification services, has become an equity stakeholder in ACT LabDealroom has a profile for this one. Try Dealroom →, a consumer products testing laboratory. The deal expands Cotecna's footprint in consumer product testing — a segment that spans chemical testing, electrical and electronics, toys, softlines, and hardlines.

Financial terms of the transaction were not disclosed.

Why now? Cotecna has been on an acquisition spree, building a portfolio of specialised testing and certification businesses across geographies — from Brazil (Agrônomica) to China (Jianchuang Testing) to India (Shiva Analyticals). Taking a stake in ACT Lab fits a broader strategy of consolidating capabilities across the testing, inspection, and certification (TIC) sector, where scale and global reach increasingly matter.

Demand for product compliance verification is rising as e-commerce platforms like Amazon tighten requirements for third-party sellers. Cotecna already offers Amazon compliance verification services, making ACT Lab a natural complement.

What could go wrong? Integration risk is the obvious concern. Cotecna's portfolio now spans dozens of subsidiaries and country operations. Managing a sprawling network of testing labs without diluting quality or operational focus is a persistent challenge in the TIC industry.

The signal: ACT Lab is classified as an early-growth company specialising in global consumer product safety compliance testing, making it a textbook bolt-on for a mature corporate acquirer like Cotecna looking to deepen category expertise rather than build it from scratch. The deal underscores a wider pattern in the TIC sector: mature players using strategic equity stakes — rather than full buyouts — to extend their reach into fast-growing niches while keeping integration lighter.

Read more: cotecna.com